Surgically Resected Isolated Hepatic Metastasis from Non-small Cell Lung Cancer: A Case Report  by Kim, Kyu-Sik et al.
CASE REPORT
Surgically Resected Isolated Hepatic Metastasis from
Non-small Cell Lung Cancer: A Case Report
Kyu-Sik Kim,*† Kook-Joo Na,*‡ Yun-Hyeon Kim,*§ Sung-Ja Ahn,* Hee-Seung Bom,*¶
Chol-Kyoon Cho,** Hyun-Jong Kim,** Yu-Il Kim,† Sung-Chul Lim,† Soo-Ock Kim,† In-Jae Oh,†
Sang-Yun Song,*‡ Chan Choi,*†† and Young-Chul Kim*†
We treated a patient with non-small cell lung cancer (NSCLC) and
an isolated hepatic metastasis. He was a 56-year-old male who
underwent right pneumonectomy after concurrent chemoradiation
therapy (etoposidecisplatin) with the diagnosis of stage IIIA squa-
mous cell lung carcinoma. Seven months later, an isolated hepatic
metastasis was found on a PET–CT scan. Hepatic segmentectomy
was performed, and the pathology showed squamous cell carcinoma.
Adjuvant chemotherapy with five cycles of gemcitabine and cispla-
tin was also given. The patient has been followed with PET–CT and
CT scanning every 6 months, and there is no evidence of relapse at
more than 5 years after the diagnosis of NSCLC. This shows that the
surgical resection of an isolated hepatic metastasis may be an option
in carefully selected patients with NSCLC without evidence of
disease outside the liver.
(J Thorac Oncol. 2006;1: 494–496)
Lung cancer has been the leading cause of cancer death inSouth Korea, as in many other parts of the world, since the
year 2000.1 The global burden of lung cancer continues to
rise,2 and at least 30% of lung cancer patients are diagnosed
with stage IV disease.3 Furthermore, even after treatment
with curative intent, many patients relapse with disease in
distant organs, such as the brain, liver, adrenals, and bone.
Conventional treatment of relapsed non-small cell lung
cancer (NSCLC) with metastases in distant organs is pallia-
tive in most patients. The surgical resection of an isolated
metastasis to the brain followed by whole-brain radiation
therapy (WBRT) is superior to WBRT alone,4 but there is
insufficient evidence to support resection of solitary adrenal
or liver metastasis from lung cancer. In addition, surgery is
contraindicated in the majority of patients with metastasis to
the liver because of the number or distribution of metastases
or the presence of extrahepatic disease. Recently, we experi-
enced a case of NSCLC with an isolated liver metastasis that
has been disease-free for more than 5 years after the diagnosis
of NSCLC.
CASE REPORT
A 55-year-old man presented to us with a 1-year history
of exertional dyspnea and a 1-month history of hemoptysis.
He was a 37 pack-years ex-smoker who had quit smoking 2
years earlier and had an otherwise unremarkable past medical
history.
Physical examination revealed decreased breath sounds
in the right upper lung field with no superficial lymphade-
nopathy. A chest radiograph and computed tomography (CT)
showed a mass measuring 6.5  4 cm in the right upper lobe
with atelectasis and encasement of the superior vena cava
(Fig. 1). The right lower paratracheal, tracheobronchial, and
aortopulmonary lymph nodes were grossly enlarged. There
was no metastasis to any intra-abdominal organ.
Fiberoptic bronchoscopy showed a stenotic lesion at the
opening of the right upper lobe bronchus. Bronchoscopic
biopsy on 19 December 2000 confirmed the diagnosis of
squamous carcinoma. A routine metastatic workup revealed
normal liver, spleen, adrenals, and bone with no bony metas-
tases. His clinical stage was T3N2M0 (stage IIIA), without
PET scan and mediastinoscopy.
Two cycles of chemotherapy with oral etoposide (50
mg/m2/day from day 1 to 14) and cisplatin (60 mg/m2) every
3 weeks with concurrent radiation therapy (6000 cGy) were
given. A repeat CT scan taken after chemoradiation therapy
showed regression of the disease with a decrease in the size
of the tumor and mediastinal lymphadenopathy. On 7 March
2001, right pneumonectomy and mediastinal lymph nodes
dissection confirmed the pathologic stage as IA (pT1N0M0).
Seven months later, an isolated hepatic metastasis was
found on a PET–CT scan (Fig. 2). A right caudate lobe
segmentectomy was performed on 15 October 2001. The
pathologic diagnosis of the resected liver was metastatic
squamous cell carcinoma with the same histology as the lung
cancer. Subsequently, adjuvant chemotherapy with five cy-
cles of three weekly gemcitabine treatments (1250 mg/m2
days 1 and 8) and cisplatin (70 mg/m2) was given. Another
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PET–CT scan on 13 December 2004 showed no evidence of
residual malignancy. The patient has been followed with CT
scanning every 6 months, and there is no evidence of relapse
more than 5 years after the diagnosis of NSCLC (Fig. 3A
and 3B).
DISCUSSION
The routine use of spiral and multi-slice CT scanning
has increased the ability to identify distant metastases of the
liver and adrenal glands. Metastasis of lung cancer to the liver
has a poor prognosis, and the majority of patients with
metastatic disease to the liver are not candidates for surgery
because of the number or distribution of metastases or the
presence of extrahepatic disease.
There are some rules for the resection of distant me-
tastasis in non-small cell lung cancer (NSCLC). According to
the revised guidelines of the American Society of Clinical
Oncology for unresectable NSCLC,4 the resection of isolated
cerebral metastasis followed by WBRT is superior to WBRT
alone in patients with controlled disease outside the brain.5,6
Although feasible in selected patients, there is insufficient
evidence to support routine resection of solitary adrenal
metastasis.7,8
Currently, there are no published guidelines concerning
the surgical resection of isolated hepatic metastasis from lung
cancer. We found one case report by Nagashima et al. of
long-term survival (5 years and 2 months) after surgical
resection of a liver metastasis from lung cancer in a 71-year-
old male (stage IB, adenocarcinoma).9
FIGURE 1. Initial chest CT scan at diagnosis showing a 6.5
 4.0-cm, lobulated, contoured mass in the right upper
lobe with atelectasis and encasement of the superior vena
cava.
FIGURE 2. Positron emission tomography (A) and abdomi-
nal CT (B) scans showing an isolated hypermetabolic lesion
(arrow) in the caudate lobe of the liver.
FIGURE 3. Chest (A) and abdominal (B) CT scans taken on
2 January 2006 showing no evidence of tumor recurrence at
the sites of the right pneumonectomy or liver segmentec-
tomy.
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Our result confirms that surgical resection of an isolated
hepatic metastasis may be an option in carefully selected
patients with lung cancer and with no evidence of disease
outside the liver.
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